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Abstract
Objective: To investigate the role and clinical significance of changes of levels of soluble intercellular
adhesion molecule-1 in the process of peritonitis in peritoneal dialysis patients.
Methods: A total of 50 patients on continuous ambulatory peritoneal dialysis in the Shanghai
Changhai Hospital between May 1999 and July 2000 were enrolled into this study. They were
assigned to two groups according to diagnostic standard of peritonitis–Group A, with episodes of
peritonitis; Group B, in the absence of peritonitis. The serum and peritoneal effluent levels of soluble
intercellular adhesion molecule-1 during and after peritonitis were assessed by using sandwiched
enzyme-linked immunosorbent assay.
Results: The serum levels of soluble intercellular adhesion molecule-1 in Group A were significantly
lower compared with Group B (214.5 ± 90.7 vs 511.2 ± 124.7 ng/mL; p<0.01). The peritoneal
effluent levels of soluble intercellular adhesion molecule-1 in Group A were significantly higher
than those in Group B (5.8 ± 1.6 vs 2.1 ± 0.9 ng/mL; p<0.01). For Group A, after treatment of
peritonitis, the serum levels of soluble intercellular adhesion molecule-1 profoundly increased to
506.1 ± 107.8 ng/mL and the peritoneal effluent levels of soluble intercellular adhesion molecule-
1 markedly decreased to 3.9 ± 1.1 ng/mL, compared with those during peritonitis, respectively
(p<0.01).
Conclusion: The study showed that increased peritoneal effluent levels of soluble intercellular
adhesion molecule-1 during peritonitis possibly activate or damage peritoneal mesothelial cells.
Monitoring changes of levels of soluble intercellular adhesion molecule-1 in peritoneal dialysis
fluid may be useful for analyzing the process of peritonitis.
Key words: Cell adhesion, Enzyme-linked immunosorbent assay, Integrins, Leukocytes/physiology, Molecular
structure
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Blood samples and peritoneal effluents of the overnight
dwell were obtained from these patients. For Group A,
both blood samples and peritoneal effluents, including
the moment the diagnosis of peritonitis was made and
after 21 days of treatment of peritonitis, were also
obtained. Concentrations for sICAM-1 were determined
by enzyme-linked immunosorbent assay using standard
kits (Sigma Corp.). The concentration of sICAM-1 was
estimated with reference to standard curves performed
with the corresponding recombinant molecules.
All data are expressed as mean ± standard deviation.
Statistical analysis was performed using the package
Statistica for Windows, version 3.1. Comparisons
between groups were performed using Student’s t test.
A p value of less than 0.05 was considered significant.
RESULTS
A follow-up was conducted on all 50 CAPD patients for
19.5 ± 3.7 months. There were 27 men and 23 women,
and their mean age was 55.2 ± 8.2 years. Background
demographic data of the two groups defined by the
diagnostic standard of peritonitis are compared in Table
1. There was no significant difference between the two
groups (p>0.05).
The serum levels of sICAM-1 in Group A were
significantly lower than those in Group B (214.5 ± 90.7
vs 511.2 ± 124.7 ng/mL, respectively; p<0.01). The
peritoneal effluent levels of sICAM-1 were significantly
higher than those in Group B (5.8 ± 1.6 vs 2.1 ± 0.9 ng/mL,
INTRODUCTION
Adhesion molecules are a heterogeneous group of ligand/
receptor molecules that mediate cell adhesion either to
other cells or to the extracellular matrix. Cell adhesion
is of fundamental importance to many processes,
including cell differentiation and organization in tissues
(1), recirculation and migration of leukocytes (2),
activation and intercommunication of immune cells (3),
and growth and metastasis of tumor cells (4). Adhesion
molecules can be separated into three main groups on
the basis of molecular, structural, and functional
differences: the immunoglobulin family, which includes
intercellular adhesion molecule-1 (ICAM-1) and vascular
cell adhesion molecule-1 (VCAM-1), the integrin family,
and the selectins (P-selectin, L-selectin, and E-selectin).
In addition to being expressed on the surface of various
cells (mainly endothelial cells and circulating blood cells
such as leukocytes and platelets), adhesion molecules
can be detected as soluble forms in the circulation (5,6).
Circulating soluble adhesion molecules seem to be
biologically active, and increased levels have been reported
in several conditions, including septic shock, diabetes,
atherosclerosis, vasculitis, and Grave’s disease (7,8).
Peritonitis is a major cause of mortality and morbility in
peritoneal dialysis (9). Because an impaired immune
system is related to the occurrence of peritonitis, the aim
of this study was to measure the serum and peritoneal
effluent levels of soluble ICAM-1 (sICAM-1) in patients
on long-term continuous ambulatory peritoneal dialysis
(CAPD), including episodes of peritonitis and absence
of peritonitis, and study the relationships between
changing levels of sICAM-1 and peritonitis.
METHODS
A total of 50 CAPD patients who received dialysis in
the Changhai hospital between May 1999 and July 2001
were enrolled into this study. According to the diagnostic
standard of peritonitis, these patients were divided into
two groups: 1. patients with episodes of peritonitis
(Group A), in which the peritonitis rate was one per 16
patient-months; and 2. patients in absence of peritonitis
(Group B), who never had peritonitis during the follow-
up periods. The standard treatment for CAPD peritonitis
was continuous intraperitoneal cefazolin plus tobramycin
for 21 days.
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Table 1. Background demographic data of the two groups defined
by the diagnostic standard of peritonitis.
Group A Group B
No. of cases  24 26
Sex ratio (M/F) 15:9 19:7
Age, years 54.3 ± 6.5 56.9 ± 9.2
Underlying renal diagnosis
  Glomerulonephritis 11 17
  Hypertension 5 2
  Diabetes 1 3
  Polycystic 3 1
  Other/unknown 4 3
Duration of PD, months 18.8 ± 2.7 20.7 ± 4.3
PD = peritoneal dialysis
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respectively; p<0.01). For Group A, after treatment of
peritonitis, the serum levels of sICAM-1 (506.1 ± 107.8
ng/mL) significantly increased compared with those
during peritonitis (p<0.01), whereas the peritoneal
effluent levels of sICAM-1 (3.9 ± 1.1 ng/mL) markedly
decreased compared with those during peritonitis (p
<0.01).
DISCUSSION
There is increasing interest in the soluble forms of
adhesion molecules. It is thought that they may be
involved in leukocyte-endothelial cell interaction because
their ligands are present on circulating leukocytes, and
there may be a role for these molecules in acute and/or
chronic inflammation, in atherosclerosis, and connective
tissue diseases (10,11). Findings also indicate that
increased levels of circulating molecules such as sICAM-
1 could protect from autoimmunity (12).
In this study, we found that the peritoneal effluent levels
of sICAM-1 were significantly higher in Group A than
in Group B. The mechanism responsible for this can only
be speculative for the moment. During peritonitis,
cytokines stimulation, such as interleukin-1 or tumor
necrosis factor-α, can mediate and upregulate the
expression of ICAM-1 on the surface of peritoneal
mesothelial cells, which is followed by the release of
sICAM-1 by proteolytic cleavage at or near the cellular
membrane without cell necrosis occurring (13). It is
therefore possible that cytokines may contribute to the
increased peritoneal effluent levels of sICAM-1 in CAPD
peritonitis patients by promoting the production of
sICAM-1 molecules. Meanwhile, we found that the
serum levels of sICAM-1 profoundly decreased in these
patients. However, the reason for it cannot be explained
with present knowledge.
The clinical significance of increased levels of circulating
adhesion molecules is unclear (14,15). The precise source
of the increases in soluble molecules will considerably
aid the interpretation of these findings. Membrane-bound
ICAM-1 are found on peritoneal mesothelial cells and a
diverse range of other cell types (16), but the cellular
source for sICAM-1 in vivo still has not been definitively
established. The circulating levels of these molecules
may be regarded as markers for the extent of an
inflammatory process, as suggested in particular for
sICAM-1, or for peritoneal mesothelium damage, or
both. The present study showed that the increased
peritoneal effluent levels of sICAM-1 were corrected
after treatment of peritonitis, which seems to reveal a
correlation between changes of levels of sICAM-1 and
the process of peritonitis. However, the physiological
role of adhesion molecules has yet to be fully clarified.
In conclusion, increased peritoneal effluent levels of
sICAM-1 during CAPD peritonitis suggest the possibility
of peritoneal mesothelial cell activation or damage, and
it has also been suggested that peritoneal mesothelial cells
are subject to inflammatory stimuli. The finding may lead
to more understanding of the process of peritonitis. The
clinical use of monitoring changes of peritoneal effluent
levels of sICAM-1 during peritonitis remains to be
elucidated.
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